Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04915235Unknown

Prevalence and Prognosis of Cardiac Amiloidosis in Turkey

Role: lead

NCT04241770Unknown

TURKish Acute Myocardial Infarction Registry

Role: lead

NCT04069598Unknown

Statin Intolerance in Patients With Myocardial Infarction

Role: lead

NCT03110250Completed

Familial Hypercholesterolemia in Turkey (A-HIT2)

Role: collaborator

NCT03364140Unknown

A Registry of Peripartum Cardiomyopathy in Turkey

Role: collaborator

NCT02347982Completed

Epidemiology of Cardiovascular Disease in Elderly Turkish Population

Role: lead

All 6 trials loaded